Vanguard Total Inflation-Protected Securities ETF (VTP) Stock Price

77.0002 ▲ +0.0052 (+0.01%)
Open: 77.08 Vol: 14.89K Day's range: 76.98 - 77.08 Jun 02, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VTP Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 77.00▼ 77.01▼ 77.01▼ 76.93▲ 76.80▲
MA10 76.98▲ 76.97▲ 76.97▲ 76.67▲ 76.76▲
MA20 76.83▲ 76.76▲ 76.75▲ 76.77▲ 76.55▲
MA50 76.67▲ 76.71▲ 76.75▲ 76.58▲ N/A    
MA100 76.71▲ 76.57▲ 76.54▲ 76.47▲ N/A    
MA200 76.60▲ 76.56▲ 76.51▲ 76.54▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.012▲ 0.031▲ 0.032▲ 0.039▲ 0.049▲
RSI 65.306▲ 65.271▲ 63.878▲ 59.445▲ 57.467▲
STOCH 77.378     88.763▲ 88.763▲ 70.414     69.096    
WILL %R -11.475▲ -9.589▲ -9.589▲ -24.675▲ -33.913    
CCI 54.377     57.500     57.500     89.701     74.056    
Latest Filters Detected On VTP
CDL $VTP Marubozu Candlestick Pattern Detected Set Alert
Vanguard Total Inflation-Protected Securities ETF News
Arbutus Biopharma Reports Positive Phase 2a Results for Imdusiran in Combination with VTP-300 and Low Dose Nivolumab in Chronic Hepatitis B Patients at EASL 2025
Tuesday, May 06, 2025 11:10 PM
Arbutus Biopharma Corporation announced promising data from a late-breaker poster presentation at the EASL Congress 2025, revealing that its treatment combining imdusiran, a RNAi therapeutic, with VTP ...
Vaccitech’s VTP-300 was Well-Tolerated and Induced T cells against all targeted HBV antigens in both Healthy Volunteers and Patients with Chronic HBV Infection in Interim ...
Friday, November 12, 2021 05:00 AM
Interim data from two studies, HBV001 and HBV002, showed that in chronic Hepatitis B (CHB) patients the heterologous prime-boost vector combination, ChAdOx1-HBV + MVA-HBV (VTP-300), induced robust T ...
Vaccitech, the company that developed the AstraZeneca COVID-19 shot, files for a Nasdaq IPO
Monday, April 12, 2021 01:09 AM
U.K. vaccine and cancer biotech Vaccitech, now famous (and perhaps in some quarters, infamous) for its tech that delivered the AstraZeneca-University of Oxford COVID-19 vaccine, is gunning for an IPO.
VTP historical stock data
date open high low close volume
02/06/26 77.08 77.08 76.98 77.0002 14,892
01/06/26 76.94 77.03 76.881 76.995 33,135
29/05/26 76.99 77.30 76.92 76.985 29,951
28/05/26 76.87 77.06 76.825 76.93 32,077
27/05/26 76.75 76.82 76.7101 76.76 25,392
26/05/26 76.70 76.72 76.59 76.72 71,232
22/05/26 76.64 76.68 76.26 76.37 28,100
21/05/26 76.36 77.155 76.31 76.3599 15,807
20/05/26 76.23 76.525 76.225 76.37 69,443
19/05/26 76.34 76.34 76.085 76.22 21,670
Quote Details
52wk Low:74.995
52wk High:79.365
Vol:14.89K
Avg Vol(3m):344.9K
1Y Chng:+0.00%
1M Chng:+0.48%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00